Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Malignant Melanoma

  Free Subscription


Articles published in PLoS Genet

Retrieve available abstracts of 10 articles:
HTML format
Text format



Single Articles


    December 2018
  1. ELLIOTT K, Bostrom M, Filges S, Lindberg M, et al
    Elevated pyrimidine dimer formation at distinct genomic bases underlies promoter mutation hotspots in UV-exposed cancers.
    PLoS Genet. 2018;14:e1007849.
    PubMed     Text format     Abstract available


    November 2018
  2. BROWN AJ, Mao P, Smerdon MJ, Wyrick JJ, et al
    Nucleosome positions establish an extended mutation signature in melanoma.
    PLoS Genet. 2018;14:e1007823.
    PubMed     Text format     Abstract available


    September 2018
  3. HENDRICKS WPD, Zismann V, Sivaprakasam K, Legendre C, et al
    Somatic inactivating PTPRJ mutations and dysregulated pathways identified in canine malignant melanoma by integrated comparative genomic analysis.
    PLoS Genet. 2018;14:e1007589.
    PubMed     Text format     Abstract available


    August 2017
  4. SCAHILL CM, Digby Z, Sealy IM, Wojciechowska S, et al
    Loss of the chromatin modifier Kdm2aa causes BrafV600E-independent spontaneous melanoma in zebrafish.
    PLoS Genet. 2017;13:e1006959.
    PubMed     Text format     Abstract available


  5. CAIRNEY CJ, Godwin LS, Bilsland AE, Burns S, et al
    A 'synthetic-sickness' screen for senescence re-engagement targets in mutant cancer backgrounds.
    PLoS Genet. 2017;13:e1006942.
    PubMed     Text format     Abstract available


    July 2017
  6. RUIZ R, Jahid S, Harris M, Marzese DM, et al
    The RhoJ-BAD signaling network: An Achilles' heel for BRAF mutant melanomas.
    PLoS Genet. 2017;13:e1006913.
    PubMed     Text format     Abstract available


    May 2017
  7. FREDRIKSSON NJ, Elliott K, Filges S, Van den Eynden J, et al
    Recurrent promoter mutations in melanoma are defined by an extended context-specific mutational signature.
    PLoS Genet. 2017;13:e1006773.
    PubMed     Text format     Abstract available


    December 2016
  8. PYTEL D, Gao Y, Mackiewicz K, Katlinskaya YV, et al
    PERK Is a Haploinsufficient Tumor Suppressor: Gene Dose Determines Tumor-Suppressive Versus Tumor Promoting Properties of PERK in Melanoma.
    PLoS Genet. 2016;12:e1006518.
    PubMed     Text format     Abstract available


    July 2016
  9. UNDERHILL HR, Kitzman JO, Hellwig S, Welker NC, et al
    Fragment Length of Circulating Tumor DNA.
    PLoS Genet. 2016;12:e1006162.
    PubMed     Text format     Abstract available


    June 2016
  10. ZHAO B, Pritchard JR
    Inherited Disease Genetics Improves the Identification of Cancer-Associated Genes.
    PLoS Genet. 2016;12:e1006081.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: